Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Servier Laboratories (Aust) Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (65)
Cancellation by sponsor (13)
Australian public assessment report (AusPar) (9)
Designation or determination (4)
Prescription medicine registration (4)
Prescription medicine decision summary (3)
Prescription medicine evaluation (2)

Date

2026 (2)
2025 (4)
2024 (18)
2023 (16)
2022 (1)
2021 (6)
2019 (1)
2018 (1)
2017 (4)
2016 (8)
2014 (1)
2013 (8)
2012 (2)
2010 (11)
2009 (3)
2007 (4)
2006 (2)
2005 (3)
2003 (1)
1998 (1)
1993 (1)
1992 (2)

Search

Sponsor content

100 result(s) found, displaying 41 to 50

MUPHORAN fotemustine 208mg powder for injection vial and diluent ampoule Cancelled under Section 30(1)(c) of the Act

20 October 2022

Cancellation by sponsor

Requested by Servier Laboratories (Aust) Pty Ltd
PERINDOPRIL AND INDAPAMIDE AN 4/1.25 perindopril erbumine 4mg / indapamide hemihydrate 1.25mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 September 2021

Cancellation by sponsor

Requested by Servier Laboratories (Aust) Pty Ltd
PERINDOPRIL AN perindopril erbumine 8mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 September 2021

Cancellation by sponsor

Requested by Servier Laboratories (Aust) Pty Ltd
PERINDOPRIL AN perindopril erbumine 4mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 September 2021

Cancellation by sponsor

Requested by Servier Laboratories (Aust) Pty Ltd
PERINDOPRIL AN perindopril erbumine 2mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 September 2021

Cancellation by sponsor

Requested by Servier Laboratories (Aust) Pty Ltd
ONCASPAR pegaspargase 3750 units/5mL injection solution vial Cancelled under Section 30(1)(c) of the Act

1 June 2021

Cancellation by sponsor

Requested by Servier Laboratories (Aust) Pty Ltd
ONCASPAR pegaspargase 3750 units/5mL powder for solution injection/infusion vial (303807)

8 March 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ONCASPAR pegaspargase 3750 units/5mL powder for solution injection/infusion vial.
DIAMICRON MR gliclazide 30mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

3 May 2021

Cancellation by sponsor

Requested by Servier Laboratories (Aust) Pty Ltd
LONSURF 15/6.14 trifluridine 15 mg/ tipiracil hydrochloride 7.065 mg (equivalent to tipiracil 6.14 mg) film-coated tablet blister pack (273239)

23 May 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LONSURF 15/6.14 trifluridine 15 mg/ tipiracil hydrochloride 7.065 mg (equivalent to tipiracil 6.14 mg) film-coated tablet blister pack.
ORCANTAS 15/6.14 trifluridine 15 mg/ tipiracil hydrochloride 7.065 mg (equivalent to tipiracil 6.14 mg) film-coated tablet blister pack (273237)

23 May 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ORCANTAS 15/6.14 trifluridine 15 mg/ tipiracil hydrochloride 7.065 mg (equivalent to tipiracil 6.14 mg) film-coated tablet blister pack.

Pages

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Current page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.